Page last updated: 2024-08-24

topotecan and Persistent Fetal Vasculature Syndrome

topotecan has been researched along with Persistent Fetal Vasculature Syndrome in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, Y; Cheng, C; Doughman, YQ; Dunwoodie, SL; Ebrahem, Q; Huang, TQ; Wang, Y; Watanabe, M; Yang, YC	1

Other Studies

1 other study(ies) available for topotecan and Persistent Fetal Vasculature Syndrome

Article	Year
Deletion of HIF-1α partially rescues the abnormal hyaloid vascular system in Cited2 conditional knockout mouse eyes. Molecular vision, 2012, Volume: 18 Topics: Animals; Cell Differentiation; Disease Models, Animal; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Lens, Crystalline; Mice; Mice, Knockout; Persistent Hyperplastic Primary Vitreous; Protein Binding; Repressor Proteins; Sequence Deletion; Topoisomerase I Inhibitors; Topotecan; Trans-Activators; Vascular Endothelial Growth Factor A	2012

Article

Year

Deletion of HIF-1α partially rescues the abnormal hyaloid vascular system in Cited2 conditional knockout mouse eyes.

Molecular vision, 2012, Volume: 18

Topics: Animals; Cell Differentiation; Disease Models, Animal; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Lens, Crystalline; Mice; Mice, Knockout; Persistent Hyperplastic Primary Vitreous; Protein Binding; Repressor Proteins; Sequence Deletion; Topoisomerase I Inhibitors; Topotecan; Trans-Activators; Vascular Endothelial Growth Factor A

2012